Management of Diabetes in Diabetic Kidney Disease: Are We Doing It Right?

November 18, 2016 | 02:00 PM - 04:00 PM

Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.

Add to Outlook Calendar Add to Google Calendar Add to Yahoo! Calendar Add to iCal Calendar

Clinical Practice Session

Management of Diabetes in Diabetic Kidney Disease: Are We Doing It Right?

November 18, 2016 | 02:00 PM - 04:00 PM

Location: W179

Session Description

This session updates practicing physicians on the management of diabetes in patients affected by diabetic kidney disease (DKD). In particular, the advantages of high glucose control and the safety and potential beneficial effects of insulin sensitizers, incretins, and sodium-glucose co-transporter type 2 (SGLT2) inhibitors are reviewed.

Session Objectives

Upon completion of this session, the participant will be able to: 1. explain the importance and validity of diabetes monitoring in DKD/ESRD; 2. analyze the pro and cons of insulin sensitizers in DKD; 3. discuss potential beneficial effects of SGLT2 inhibitors for renoprotection; and 4. describe the biology of incretin-based therapy in DKD.

Learning Pathways

  • Diabetes and Metabolism
  • Chronic Kidney Disease

Moderators

  • Vlado Perkovic, MBBS, FASN
  • Peter Rossing, MD

Lectures

How and Why to Monitor Diabetes in CKD and ESRD Add to your Outlook, Google, Yahoo, or Apple iCal Calendar
02:00 PM - 02:30 PM
Mark E. Molitch, MD

Upcoming New Targets for DKD Add to your Outlook, Google, Yahoo, or Apple iCal Calendar
02:30 PM - 03:00 PM
Rajiv Agarwal, MBBS, MD, FASN

DKD: Are SGLT2 Inhibitors the Solution? Add to your Outlook, Google, Yahoo, or Apple iCal Calendar
03:00 PM - 03:30 PM
David Cherney, MD, PhD

Gut–Renal Axis: Do Incretin-Based Agents Confer Renoprotection in Diabetes? Add to your Outlook, Google, Yahoo, or Apple iCal Calendar
03:30 PM - 04:00 PM
Marcel H.A. Muskiet, MD